The Valley Desk

NCT00979992 · Interventional trial

Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

Overall registry status Completed

Phase 2

Conditions Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov